BIIB 063Alternative Names: anti-CD40 - Biogen; BIIB063
Latest Information Update: 24 Sep 2015
At a glance
- Originator Biogen
- Class Monoclonal antibodies
- Mechanism of Action CD40 ligand inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Sjogren's syndrome